AI Accelerates Early Cancer Drug Discovery, India Poised for Regulatory Reforms
Dr. Siddhartha Mukherjee, co-founder and CEO of Manas AI, highlighted at the Hindustan Times Leadership Summit 2026 that artificial intelligence is significantly reducing early-stage cancer drug discovery from nearly eight years to just three or four months. By combining machine learning with physics and chemistry principles, Manas AI designs new drug molecules rapidly, accelerating testing cycles. Mukherjee emphasized that while AI speeds early discovery, clinical trials and regulatory processes still delay drug development. He also noted India's potential to lead in this field with regulatory reforms to lower drug costs and increase approvals.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 48/100.
Outlets measured: mint, hindustantimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
hindustantimes broke this story on 14 Nov, 01:12 pm. Other outlets followed.